A detailed history of Inspire Investing, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Inspire Investing, LLC holds 12,082 shares of VCYT stock, worth $501,886. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,082
Previous 16,462 26.61%
Holding current value
$501,886
Previous $356,000 15.45%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$21.0 - $35.25 $91,980 - $154,395
-4,380 Reduced 26.61%
12,082 $411,000
Q2 2024

Aug 12, 2024

BUY
$18.86 - $23.55 $6,412 - $8,007
340 Added 2.11%
16,462 $356,000
Q1 2024

May 07, 2024

BUY
$21.0 - $29.1 $44,919 - $62,244
2,139 Added 15.3%
16,122 $357,000
Q4 2023

Feb 12, 2024

BUY
$19.72 - $28.68 $4,851 - $7,055
246 Added 1.79%
13,983 $384,000
Q3 2023

Oct 26, 2023

BUY
$22.33 - $29.92 $306,747 - $411,011
13,737 New
13,737 $306,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.